Results 131 to 140 of about 3,310,854 (363)

Tannin: An Insight into its Cosmeceutical Properties and Uses

open access: yesGlobal Challenges, EarlyView.
Filling a gap in the literature, this study identifies the emerging uses of tannin as cosmeceutical ingredient in skin and hair care products. The account offers also a green chemistry, health and economic perspective on future developments concerning the use of tannins in cosmetic products widely employed worldwide such as hair dyes and hair relaxers.
Rosaria Ciriminna   +6 more
wiley   +1 more source

Association of cetuximab with adverse pulmonary events in cancer patients: a comprehensive review

open access: yesJournal of Experimental & Clinical Cancer Research, 2009
Compounds derived from biologic sources, or biologicals, are increasingly utilized as therapeutic agents in malignancy. Development of anti-cancer targeted therapies from biologics is increasingly being utilized. Cetuximab, a chimeric monoclonal antibody,
Lu Jason   +5 more
doaj   +1 more source

Bitter Taste Receptor Agonists Induce Apoptosis in Papillary Thyroid Cancer

open access: yesHead &Neck, EarlyView.
ABSTRACT Background Papillary thyroid carcinoma (PTC) is the most common thyroid malignancy, with a 20% recurrence rate. Bitter taste receptors (T2Rs) and their genes (TAS2Rs) may regulate survival in solid tumors. This study examined T2R expression and function in PTC cells.
Kimberly Wei   +6 more
wiley   +1 more source

Liposomes and Other Nanocarriers for the Treatment of Acne Vulgaris: Improved Therapeutic Efficacy and Skin Tolerability

open access: yesPharmaceutics
Acne vulgaris is a common dermatologic disorder that affects approximately 85% of teenagers, which significantly impacts the quality of life in adolescents. It is a chronic disease of the sebaceous follicles that is multifactorial in etiology.
Nina Dragicevic, Howard I. Maibach
doaj   +1 more source

Targeted Therapies for Renal Cell Carcinoma: Review of Adverse Event Management Strategies [PDF]

open access: yes, 2017
With the advent of targeted agents for the treatment of renal cell carcinoma (RCC), overall survival has improved, and patients are being treated continuously for increasingly long periods of time.
Eisen, Tim   +7 more
core  

Combined Tumor Infiltrating Lymphocytes and PD‐L1 Status in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

open access: yesHead &Neck, EarlyView.
ABSTRACT Objectives To determine if the assessment of CD8+ tumor‐infiltrating lymphocytes (TILs) adds prognostic information to the PD‐L1 combined positive score (CPS) in recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC). Methods A retrospective case series was performed of 77 patients with R/M HNSCC between 2003 and 2019.
Catherine T. Haring   +8 more
wiley   +1 more source

Vision Changes After Head and Neck Cancer Treatment

open access: yesHead &Neck, EarlyView.
ABSTRACT Background Literature about ocular toxicity after head and neck cancer (HNC) treatment is scarce. This study aimed to describe visual function and ocular symptoms among HNC patients. Methods The study used a cross‐sectional design. Two surveys, The National Eye Institute Visual Functioning Questionnaire (NEI‐VFQ) and an Ocular Symptom Scale ...
Hsiao‐Lan Wang   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy